These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Leukemogenesis and new therapy development: the example of chronic myelogenous leukemia]. Etienne G; Mahon FX Bull Cancer; 2001 Jul; 88(7):651-8. PubMed ID: 11495816 [TBL] [Abstract][Full Text] [Related]
29. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia. Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568 [TBL] [Abstract][Full Text] [Related]
31. Long-term follow-up of Philadelphia chromosome-positive (Ph) chronic myeloid leukaemia (CML) in children and adolescents managed at a single institution over a 20-year period. Giona F; Moleti ML; Del Giudice I; Testi AM; Diverio D; De Cuia MR; Mandelli F; Foa R Br J Haematol; 2005 Sep; 130(6):970-2. PubMed ID: 16156873 [No Abstract] [Full Text] [Related]
32. Chronic myeloid leukemia in first chronic phase not responding to alpha-interferon: outcome and prognostic factors after autologous transplantation. EBMT Working Party on Chronic Leukemias. Boiron JM; Cahn JY; Meloni G; Carlo-Stella C; Bandini G; Reman O; Milpied N; Apperley J; Reiffers J Bone Marrow Transplant; 1999 Aug; 24(3):259-64. PubMed ID: 10455363 [TBL] [Abstract][Full Text] [Related]
33. [Interferon-alpha in the treatment of chronic myeloid leukemia]. Guilhot F Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394 [No Abstract] [Full Text] [Related]
35. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia. Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141 [TBL] [Abstract][Full Text] [Related]
36. [Imatinib therapy for patients with chronic myelogenous leukemia]. Usui N Gan To Kagaku Ryoho; 2005 Mar; 32(3):297-303. PubMed ID: 15791812 [TBL] [Abstract][Full Text] [Related]
37. [Therapy of chronic myelogenous leukemia in 2004]. Hochhaus A; Berger U; Hehlmann R Dtsch Med Wochenschr; 2004 Oct; 129(40):2122-7. PubMed ID: 15455305 [TBL] [Abstract][Full Text] [Related]
38. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase. Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437 [TBL] [Abstract][Full Text] [Related]
39. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers. Beksac M; Celebi H; Sargín D; Yalcin A; Topcuoglu P; Kalayoglu-Besisik S; Beyan C; Arslan O; Ozcan M; Gurman G; Ilhan O; Akan H Bone Marrow Transplant; 2003 May; 31(10):897-904. PubMed ID: 12748666 [TBL] [Abstract][Full Text] [Related]
40. Durable molecular remission in a patient with chronic myelogenous leukemia and host-derived hematopoiesis after allogeneic bone marrow transplantation. Wakui M; Okamoto S; Ishida A; Tanosaki R; Mori T; Kawai Y; Ohshima S; Ikeda Y Bone Marrow Transplant; 1996 Oct; 18(4):801-4. PubMed ID: 8899199 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]